Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction
Moumita Paul-Heng, Mario Leong, Eithne Cunningham, Daniel L. J. Bunker, Katherine Bremner, Zane Wang, Chuanmin Wang, Szun Szun Tay, Claire McGuffog, Grant J. Logan, Ian E. Alexander, Min Hu, Stephen I. Alexander, Tim D. Sparwasser, Patrick Bertolino, David G. Bowen, G. Alex Bishop, Alexandra Sharland
Moumita Paul-Heng, Mario Leong, Eithne Cunningham, Daniel L. J. Bunker, Katherine Bremner, Zane Wang, Chuanmin Wang, Szun Szun Tay, Claire McGuffog, Grant J. Logan, Ian E. Alexander, Min Hu, Stephen I. Alexander, Tim D. Sparwasser, Patrick Bertolino, David G. Bowen, G. Alex Bishop, Alexandra Sharland
View: Text | PDF
Research Article Hepatology Transplantation

Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction

  • Text
  • PDF
Abstract

Adeno-associated viral vector–mediated (AAV-mediated) expression of allogeneic major histocompatibility complex class I (MHC class I) in recipient liver induces donor-specific tolerance in mouse skin transplant models in which a class I allele (H-2Kb or H-2Kd) is mismatched between donor and recipient. Tolerance can be induced in mice primed by prior rejection of a donor-strain skin graft, as well as in naive recipients. Allogeneic MHC class I may be recognized by recipient T cells as an intact molecule (direct recognition) or may be processed and presented as an allogeneic peptide in the context of self-MHC (indirect recognition). The relative contributions of direct and indirect allorecognition to tolerance induction in this setting are unknown. Using hepatocyte-specific AAV vectors encoding WT allogeneic MHC class I molecules, or class I molecules containing a point mutation (D227K) that impedes direct recognition of intact allogeneic MHC class I by CD8+ T cells without hampering the presentation of processed peptides derived from allogeneic MHC class I, we show here that tolerance induction depends upon recognition of intact MHC class I. Indirect recognition alone yielded a modest prolongation of subsequent skin graft survival, attributable to the generation of CD4+ Tregs, but it was not sufficient to induce tolerance.

Authors

Moumita Paul-Heng, Mario Leong, Eithne Cunningham, Daniel L. J. Bunker, Katherine Bremner, Zane Wang, Chuanmin Wang, Szun Szun Tay, Claire McGuffog, Grant J. Logan, Ian E. Alexander, Min Hu, Stephen I. Alexander, Tim D. Sparwasser, Patrick Bertolino, David G. Bowen, G. Alex Bishop, Alexandra Sharland

×

Figure 1

Dose-dependent prolongation of Kd-bearing skin graft survival after transduction of recipient hepatocytes with AAV-Kd.

Options: View larger image (or click on image) Download as PowerPoint
Dose-dependent prolongation of Kd-bearing skin graft survival after tran...
(A) C57BL/6 mice (n = 6/group) were inoculated with AAV-Kd at doses ranging from 5 × 109 to 5 × 1011 vector genome copies (vgc) or with 5 × 1011 vgc of a control vector encoding the third-party MHC class I molecule H-2Kk. Skin grafts were performed 7 days later. Graft survival was analyzed using the log-rank (Mantel-Cox) test. Syngeneic skin grafts from C57BL/6 donors survived indefinitely. Median survival time (MST) of B6.Kd skin grafts to uninjected C57BL/6 recipients (n = 12) was 15 days. AAV-Kk did not extend survival (MST 19 days; P = 0.58), whereas a dose-dependent survival prolongation was noted with AAV-Kd, culminating in 100% survival at d100 after transplantation in mice receiving 5 × 1011 vgc AAV-Kd (P = 0.0008 vs. 5 × 1011 vgc AAV-Kk). (B) C57BL/6 mice were first primed by receiving a B6.Kd skin graft. Mice were rested for 30–35 days to allow a memory response to develop and then received a secondary graft of B6.Kd skin. A modest acceleration of rejection tempo was observed in primed mice (n = 6), compared with unprimed recipients of grafts from the same donor (n = 6; MST 17 days vs. 22.5 days; P = 0.03; Gehan-Breslow-Wilcoxon test). (C) C57BL/6 mice were primed and rested as above and were then inoculated with AAV-Kd at 5 × 1010 (n = 3) or 5 × 1011 (n = 6) vgc i.v., followed after an additional 7 days by a secondary graft. Skin graft survival was analyzed as for A. Median survival of secondary B6.Kd grafts was not prolonged in primed mice treated with 5 × 1010 vgc AAV-Kd, while all mice inoculated with 5 × 1011 vgc AAV-Kd accepted a secondary graft indefinitely (P = 0.0039 compared with 5 × 1010 vgc AAV-Kd). (D) At d14–16 after transplant, histological examination of B6.Kd allografts to control mice showed complete rejection, with extensive infiltration of the graft and loss of the graft epithelium. (E–G) In contrast, B6.Kd grafts to B10.BR mice inoculated with 5 × 1011 vgc AAV-Kd had normal histological appearances at d14–16 (E) and d100 (G), comparable with those of syngeneic grafts (F). (H–J) Expression of H-2Kd in the tolerated grafts increased early after transplantation (I and J) compared with that in freshly collected B6.Kd tail skin (H). (K) Ongoing H-2Kd expression was detectable in tolerated grafts and had returned to baseline levels by d100. Magnification, 200× for D–K.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts